Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
Latest reported KYMR revenue for 2026-06-30 was $99.4M. Net income was -$130.4M. KYMR currently screens at market cap $7.39B.
Use this KYMR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the KYMR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the KYMR SEC filings page. Lician reads the product cache first so this HTML stays unique to Kymera Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full KYMR income, balance, and cash tables.